Lotus Bio-Technology Development Corp. (LBTD)

USD 0.01

(0.0%)

Operating Expenses Summary of Lotus Bio-Technology Development Corp.

Lotus Bio-Technology Development Corp.'s latest annual operating expenses in 2023 was - USD , down 0.0% from previous year.
Lotus Bio-Technology Development Corp.'s latest quarterly operating expenses in 2023 FY was - USD , down 0.0% from previous quarter.
Lotus Bio-Technology Development Corp. reported a annual operating expenses of - USD in annual operating expenses 2022, down 0.0% from previous year.
Lotus Bio-Technology Development Corp. reported a annual operating expenses of - USD in annual operating expenses 2021, down 0.0% from previous year.
Lotus Bio-Technology Development Corp. reported a quarterly operating expenses of - USD for 2022 FY, down 0.0% from previous quarter.
Lotus Bio-Technology Development Corp. reported a quarterly operating expenses of - USD for 2021 FY, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Lotus Bio-Technology Development Corp. (2023 - 2011)

Historical Annual Operating Expenses of Lotus Bio-Technology Development Corp. (2023 - 2011)

Year	Operating Expenses	Operating Expenses Growth
2023	- USD	0.0%
2022	- USD	0.0%
2021	- USD	0.0%
2020	- USD	0.0%
2019	- USD	0.0%
2017	781.1 Thousand USD	0.0%
2016	781.1 Thousand USD	4071.68%
2015	18.72 Thousand USD	-55.04%
2014	41.64 Thousand USD	-32.92%
2013	62.07 Thousand USD	301.68%
2012	15.45 Thousand USD	-0.61%
2011	15.55 Thousand USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 FY	- USD	0.0%
2022 FY	- USD	0.0%
2021 FY	- USD	0.0%
2020 FY	- USD	0.0%
2019 FY	- USD	0.0%
2018 Q3	12.98 Thousand USD	-14.97%
2018 Q2	15.27 Thousand USD	16867.78%
2018 Q1	90.00 USD	-99.99%
2017 FY	781.1 Thousand USD	0.0%
2017 Q3	12.98 Thousand USD	317.39%
2017 Q4	758.45 Thousand USD	5740.99%
2017 Q2	3111.00 USD	106.03%
2017 Q1	1510.00 USD	-99.8%
2016 Q4	768.4 Thousand USD	11670.91%
2016 FY	781.1 Thousand USD	4071.68%
2016 Q2	4019.00 USD	86.67%
2016 Q1	2153.00 USD	108.42%
2016 Q3	6528.00 USD	62.43%
2015 Q3	12.96 Thousand USD	-28.52%
2015 FY	18.72 Thousand USD	-55.04%
2015 Q1	29.94 Thousand USD	0.21%
2015 Q2	18.13 Thousand USD	-39.45%
2015 Q4	-25.58 Thousand USD	-297.39%
2014 Q4	29.87 Thousand USD	653.35%
2014 Q2	2249.00 USD	-59.48%
2014 Q1	5550.00 USD	-76.96%
2014 FY	41.64 Thousand USD	-32.92%
2014 Q3	3966.00 USD	76.35%
2013 Q3	25.75 Thousand USD	1264.3%
2013 Q4	24.08 Thousand USD	-6.49%
2013 FY	62.07 Thousand USD	301.68%
2013 Q2	1888.00 USD	-81.65%
2013 Q1	10.28 Thousand USD	-14.13%
2012 Q3	200.00 USD	0.0%
2012 Q2	200.00 USD	-93.5%
2012 Q1	3075.00 USD	0.0%
2012 Q4	11.98 Thousand USD	5890.0%
2012 FY	15.45 Thousand USD	-0.61%
2011 FY	15.55 Thousand USD	0.0%

Peer Operating Expenses Comparison of Lotus Bio-Technology Development Corp.

Name	Operating Expenses	Operating Expenses Difference
Allied Energy Corporation	403.19 Thousand USD	100.0%
Earth Alive Clean Technologies Inc.	5.04 Million USD	100.0%
Igene Biotechnology, Inc.	990.93 Thousand USD	100.0%
MagIndustries Corp.	24.19 Million USD	100.0%
Itafos Inc.	27.99 Million USD	100.0%
Potash America, Inc.	320.37 Thousand USD	100.0%
Yara International ASA	3.02 Billion USD	100.0%
Yara International ASA	3.02 Billion USD	100.0%